DoD Says AVI Biopharma's (AVII) Flu Drug Candidate Does Not Qualify for Contract Award
AVI Biopharma (Nasdaq: AVII) receives notice from Department of Defense its proposal for full clinical development of its influenza candidate, AVI-7100 did not qualify for a contract award.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 3M Co. (MMM) Victorious in Patent Suit vs. Dental Direkt
- Sears Holdings (SHLD) Will Explore Options for KCD, SHS Businesses; CFO Schriesheim to Resign
- Air Industries Group (AIRI) Enters 452.25k Share Private Placement for Proceeds of $6.3M
Create E-mail Alert Related CategoriesCorporate News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!